Indications and uses
For the temporary relief of symptoms commonly associated with hypothyroid, such as: weakness fatigue glandular swelling irritability
For the temporary relief of symptoms commonly associated with hypothyroid, such as: weakness fatigue glandular swelling irritability
Dispense Thyroveev directly into mounth, or add recommended dosage into 8-12 oz purified (non-chlorinated) water and drink. Safe for ages 2 and up. DOSAGE BY WEIGHT 30-50 lbs (13.6-22.6 kg) 1/2 mL twice per day 50+ lbs (22.6+ kg) 1 mL twice per day
do not use if tamper seal is broken store in a cool, dry place product must not come in contact with metal do not store next to electrical devices or appliances
Antimon crud, Cobaltum nit, Nat brom HPUS, Parathormonum HPUS
Antimon iod HPUS
Aqua marina, Fucus, Ignatia HPUS
Arg iod, Badiaga, Bromium, Calc carb, Calc iod, Ferrum iod, Kali iod, Thyroidinum HPUS
Gelsemium, Sulphur iod HPUS
Gentianella am, flos, Iodium, Nat mur, Phosphoricum ac HPUS
Hydrastis HPUS
Lapis, Rosmarinus HPUS
Each active ingredient contains equal volumes of 10X, 30X, and LM1 potencies. The letter "HPUS" indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States. Product indications are based on Homeopathic Materia Medica.
Antimon crud, Cobaltum nit, Nat brom, Parathormonum HPUS...........................................................................Fatigue
Antimon iod HPUS..........................................................................................................................................Breathing trouble
Aqua marina, Fucus, Ignatia HPUS...................................................................................................................Constipation
Arg iod, Badiaga, Bromium, Calc carb, Calc iod, Ferrum iod, Kali iod, Thyroidinum HPUS.....................................Glandular swelling
Gelsemium, Sulphur iod HPUS.........................................................................................................................Weakness
Gentianella am, flos, Iodium, Nat mur, Phosphoricum ac HPUS...........................................................................Depression
Hydrastis HPUS...............................................................................................................................................Irritability
Lapis, Rosmarinus HPUS..................................................................................................................................Headache
For the temporary relief of symptoms commonly associated with hypothyroid, such as:
Ask a doctor before use if
|
When using this product use only as directed.
Stop use and ask a doctor if symptoms persist or worsen.
| If pregnant or breast-feeding, ask a health professional before use. |
Keep out of the reach of children.
| Dispense Thyroveev directly into mounth, or add recommended dosage into 8-12 oz purified (non-chlorinated) water and
drink. Safe for ages 2 and up.
DOSAGE BY WEIGHT 30-50 lbs (13.6-22.6 kg) 1/2 mL twice per day 50+ lbs (22.6+ kg) 1 mL twice per day |
citric acid, potassium sorbate, purified ionized mineral water |
| You can email us at info@hellolife.net or call us toll-free at 1.800.875.0850 Monday through Friday 9am-5pm ET |
Mftd for: HelloLife, LLC. 4460 44th St SE, Ste. C-600 Grand Rapids, MI 49512 FDA Pharmaceutical Establishment #1053442, #3009727070 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49726-025-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-f91c-f424-e053-dadaa90a57ce | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49726-025-02 | ThyroveevHyperthyroid Symptom Relief | 59 mL in 1 BOTTLE, DROPPER | LIQUID | 59 | 7 | |
| 49726-025-02 | ThyroveevHyperthyroid Symptom Relief | 1 in 1 CARTON | LIQUID | 1 | 7 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49726-025 | THYROVEEV HYPERTHYROID SYMPTOM RELIEF (ANTIMONIUM CRUDUM, ANTIMONIUM IODATUM, AQUA MARINA, ARGENTUM IODATUM, BADIAGA, BROMIUM, CALCAREA CARBONICA, CALCAREA IODATA, COBALTUM NITRICUM, FERRUM IODATUM, FUCUS, GELSEMIUM, GENTIANELLA AMARELLA FLOS, HYDRASTIS, IGNATIA, IODIUM, KALI IODATUM, LAPIS, NATRUM BROMATUM, NATRUM MURIATICUM, PARATHORMONUM, PHOSPHORICUM ACIDUM, ROSMARINUS, SULPHUR IODATUM, THYROIDINUM) LIQUID [HELLO LIFE, INC.] | 7 | Legacy NDC, 2 package rows | 20181227_2427ad19-c6a7-4323-98dc-60fabcae4d6a.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ANTIMONY TRIIODIDE | ACTIVE INGREDIENT | 52ZE5Y9Y82 | 5 | |
| ANTIMONY TRISULFIDE | ACTIVE INGREDIENT | F79059A38U | 5 | |
| BROMINE | ACTIVE INGREDIENT | SBV4XY874G | 5 | |
| CALCIUM HEXAFLUOROSILICATE | ACTIVE INGREDIENT | 2NVP93XVQ3 | 5 | |
| CALCIUM IODIDE | ACTIVE INGREDIENT | 8EKI9QEE2H | 5 | |
| COBALTOUS NITRATE HEXAHYDRATE | ACTIVE INGREDIENT | 2H2166872F | 5 | |
| FERROUS IODIDE | ACTIVE INGREDIENT | F5452U54PN | 5 | |
| FUCUS VESICULOSUS | ACTIVE INGREDIENT | 535G2ABX9M | 5 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE INGREDIENT | 639KR60Q1Q | 5 | |
| GENTIANELLA AMARELLA FLOWER | ACTIVE INGREDIENT | ZKH2SOY1AR | 5 | |
| GOLDENSEAL | ACTIVE INGREDIENT | ZW3Z11D0JV | 5 | |
| IODINE | ACTIVE INGREDIENT | 9679TC07X4 | 5 | |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | ACTIVE INGREDIENT | 2E32821G6I | 5 | |
| PARATHYROID HORMONE | ACTIVE INGREDIENT | N19A0T0E5J | 5 | |
| PHOSPHORIC ACID | ACTIVE INGREDIENT | E4GA8884NN | 5 | |
| POTASSIUM IODIDE | ACTIVE INGREDIENT | 1C4QK22F9J | 5 | |
| ROSMARINUS OFFICINALIS FLOWERING TOP | ACTIVE INGREDIENT | 8JM482TI79 | 5 | |
| SILVER IODIDE | ACTIVE INGREDIENT | 81M6Z3D1XE | 5 | |
| SODIUM BROMIDE | ACTIVE INGREDIENT | LC1V549NOM | 5 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 5 | |
| SPONGILLA LACUSTRIS | ACTIVE INGREDIENT | 6SZ0G98BHM | 5 | |
| STRYCHNOS IGNATII SEED | ACTIVE INGREDIENT | 1NM3M2487K | 5 | |
| SULFUR IODIDE | ACTIVE INGREDIENT | L6L8KA2AA0 | 5 | |
| THYROID, UNSPECIFIED | ACTIVE INGREDIENT | 0B4FDL9I6P | 5 | |
| ANTIMONY CATION (3+) | ACTIVE MOIETY | 069647RPT5 | 5 | |
| ANTIMONY TRIIODIDE | ACTIVE MOIETY | 52ZE5Y9Y82 | 5 | |
| BROMIDE ION | ACTIVE MOIETY | 952902IX06 | 5 | |
| BROMINE | ACTIVE MOIETY | SBV4XY874G | 5 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 5 | |
| CALCIUM HEXAFLUOROSILICATE | ACTIVE MOIETY | 2NVP93XVQ3 | 5 | |
| CHLORIDE ION | ACTIVE MOIETY | Q32ZN48698 | 5 | |
| COBALTOUS CATION | ACTIVE MOIETY | AI1MR454XG | 5 | |
| FERROUS IODIDE | ACTIVE MOIETY | F5452U54PN | 5 | |
| FUCUS VESICULOSUS | ACTIVE MOIETY | 535G2ABX9M | 5 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE MOIETY | 639KR60Q1Q | 5 | |
| GENTIANELLA AMARELLA FLOWER | ACTIVE MOIETY | ZKH2SOY1AR | 5 | |
| GOLDENSEAL | ACTIVE MOIETY | ZW3Z11D0JV | 5 | |
| IODIDE ION | ACTIVE MOIETY | 09G4I6V86Q | 5 | |
| IODINE | ACTIVE MOIETY | 9679TC07X4 | 5 | |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | ACTIVE MOIETY | 2E32821G6I | 5 | |
| PARATHYROID HORMONE | ACTIVE MOIETY | N19A0T0E5J | 5 | |
| PHOSPHORIC ACID | ACTIVE MOIETY | E4GA8884NN | 5 | |
| ROSMARINUS OFFICINALIS FLOWERING TOP | ACTIVE MOIETY | 8JM482TI79 | 5 | |
| SILVER IODIDE | ACTIVE MOIETY | 81M6Z3D1XE | 5 | |
| SPONGILLA LACUSTRIS | ACTIVE MOIETY | 6SZ0G98BHM | 5 | |
| STRYCHNOS IGNATII SEED | ACTIVE MOIETY | 1NM3M2487K | 5 | |
| SULFUR IODIDE | ACTIVE MOIETY | L6L8KA2AA0 | 5 | |
| THYROID, UNSPECIFIED | ACTIVE MOIETY | 0B4FDL9I6P | 5 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 5 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 5 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49726-025 | 49726-025-02 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CAPSULE / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRATHECAL | ADJ PH | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | AEROSOL, FOAM / TOPICAL | 8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, CHEWABLE / ORAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / IONTOPHORESIS | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / TOPICAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / AURICULAR (OTIC) | 0.2 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | PASTE / ORAL | 48 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRABURSAL | ADJ PH | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CONCENTRATE / ORAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EXTENDED RELEASE / ORAL | 45 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / ORAL | 914 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAVENOUS | 10 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | EMULSION / TOPICAL | 0.11 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TROCHE / ORAL | 12 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SUSPENSION / ORAL | 840 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / OPHTHALMIC | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 608 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM / SUBLINGUAL | 10 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / RECTAL | 6.67 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / RECTAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRA-ARTICULAR | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION/ DROPS / ORAL | 19 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION/ DROPS / OPHTHALMIC | 0.47 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / ORAL | 315 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRA-ARTICULAR | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / TOPICAL | 17 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SYRUP / ORAL | 2 mg/1ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / TOPICAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY, METERED / NASAL | 2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / AURICULAR (OTIC) | 0.04 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INFILTRATION | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 38 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / BUCCAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CONCENTRATE / ORAL | 5.3 mg/1ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DROPS / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / SUBCUTANEOUS | 26 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYRUP / ORAL | 722 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRALESIONAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY / NASAL | 9 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAMUSCULAR | 26 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER / ORAL | 840 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / ORAL | 446 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRACARDIAC | 1.05 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SPRAY, METERED / NASAL | 0.06 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / INTRAVENOUS | 0.2 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / IRRIGATION | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO, SUSPENSION / TOPICAL | 0.25 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / PERIDURAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SUBCUTANEOUS | 28 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / TOPICAL | 0.01 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 7df183c1-5f81-1a16-e053-2991aa0a2223 | 2427ad19-c6a7-4323-98dc-60fabcae4d6a | 2018-12-26 | Warnings | 7df183c1-5f81-1a16-e053-2991aa0a2223 2427ad19-c6a7-4323-98dc-60fabcae4d6a |
Adverse event summaries are temporarily unavailable. Other product information remains available.